Neumora Therapeutics Inc. Watch

from S-1 87 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Is Treated by the Registrant as Private or Confidential. Agreement and Plan of Merger by and Among Rbnc Therapeutics, Inc., Alairion Merger Sub I, Inc., Alairion Merger Sub II, LLC, Alairion, Inc. and John F. Dee, Solely in His Capacity as the Stockholders’ Representative Dated as of November 24, 2020

from S-1 103 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Is Treated by the Registrant as Private or Confidential. Agreement and Plan of Merger by and Among Rbnc Therapeutics, Inc., Berries Merger Sub, Inc., Blackthorn Therapeutics, Inc. and Fortis Advisors LLC, Solely in Its Capacity as the Stockholders’ Representative Dated as of June 1, 2020